Compare Archer-Daniels-Midland Co (ADM) vs Ascendis Pharma A/S (ASND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Archer-Daniels-Midland Co vs Ascendis Pharma A/S — how do they compare? Archer-Daniels-Midland Co trades at $80.75 (market cap $38.78B), while Ascendis Pharma A/S trades at $254.5 (market cap $16.67B). The key difference: Archer-Daniels-Midland Co is far larger — about 2.3× Ascendis Pharma A/S's market cap, and Archer-Daniels-Midland Co pays a 2.59% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ADM | ASND | |
|---|---|---|
Market Cap | $38.78B | $16.67B |
Sector | Consumer Staples | Health |
52-Week High | $87.32 | $277.18 |
52-Week Low | $56.00 | $189.74 |
Enterprise Value | $47.03B | $17.04B |
Dividend Yield | 2.59% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Archer-Daniels-Midland Co
Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. Additionally, the company owns an extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients. The company is also a large producer of corn-based sweeteners, starches, and ethanol.
Read more on ADM →About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →
